Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. (Q53587076)

30 June 2019

title

Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. (English)

1 reference

30 June 2019

0 references

2

Kevin J Morine

1 reference

30 June 2019

author name string

Pavan Atluri

1

1 reference

30 June 2019

George P Liao

3

1 reference

30 June 2019

Corinna M Panlilio

4

1 reference

30 June 2019

Mark F Berry

5

1 reference

30 June 2019

Vivian M Hsu

6

1 reference

30 June 2019

William Hiesinger

7

1 reference

30 June 2019

Jeffrey E Cohen

8

1 reference

30 June 2019

Y Joseph Woo

9

1 reference

30 June 2019

publication date

19 November 2006

1 reference

30 June 2019

Cellular & Molecular Biology Letters

published in

1 reference

30 June 2019

volume

12

1 reference

30 June 2019

issue

1

1 reference

30 June 2019

page(s)

127-138

1 reference

30 June 2019

https://scigraph.springernature.com/pub.10.2478/s11658-006-0058-7

exact match

0 references

cites work

Molecular properties of apelin: tissue distribution and receptor binding

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Characterization of apelin, the ligand for the APJ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Modification of the terminal residue of apelin-13 antagonizes its hypotensive action

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

Intracerebroventricular injection of apelin-13 reduces food intake in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-006-0058-7

A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11

21 January 2018

1 reference

12 December 2020

Chronic heart failure induced by coronary artery ligation in Lewis inbred rats

1 reference

12 December 2020

Apelin has in vivo inotropic effects on normal and failing hearts

1 reference

12 December 2020

Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.

1 reference

12 December 2020

10.2478/S11658-006-0058-7

Identifiers

DOI

1 reference

30 June 2019

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.2478/s11658-006-0058-7

PMCID

6275893

1 reference

30 June 2019

PubMed ID

17119870

1 reference

30 June 2019